AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Fuchs, D Jaeger, M Widner, B Wirleitner, B Artner-Dworzak, E Leblhuber, F
Citation: D. Fuchs et al., Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?, CLIN CH L M, 39(8), 2001, pp. 691-694

Authors: Gerlach, M Blum-Degen, D Ransmayr, G Leblhuber, F Pedersen, V Riederer, P
Citation: M. Gerlach et al., Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain, ALC ALCOHOL, 36(1), 2001, pp. 65-69

Authors: Gotz, ME Janetzky, B Pohli, S Gottschalk, A Gsell, W Tatschner, T Ransmayr, G Leblhuber, F Gerlach, M Reichmann, H Riederer, P Boning, J
Citation: Me. Gotz et al., Chronic alcohol consumption and cerebral indices of oxidative stress: Is there a link?, ALC CLIN EX, 25(5), 2001, pp. 717-725

Authors: Widner, B Fuchs, D Leblhuber, F Sperner-Unterweger, B
Citation: B. Widner et al., Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress?, J NE NE PSY, 70(3), 2001, pp. 419-419

Authors: Leblhuber, F Walli, J Widner, B Artner-Dworzak, E Fuchs, D Vrecko, K
Citation: F. Leblhuber et al., Homocysteine and B vitamins in dementia, AM J CLIN N, 73(1), 2001, pp. 127-128

Authors: Leblhuber, F Walli, J Artner-Dworzak, E Vrecko, K Fuchs, D
Citation: F. Leblhuber et al., Comment: treatment of hyperhomocysteinemia with folic acid, ANN PHARMAC, 34(10), 2000, pp. 1207-1208

Authors: Widner, B Leblhuber, F Walli, J Tilz, GP Demel, U Fuchs, D
Citation: B. Widner et al., Tryptophan degradation and immune activation in Alzheimer's disease, J NEURAL TR, 107(3), 2000, pp. 343-353

Authors: Leblhuber, F Walli, J Artner-Dworzak, E Vrecko, K Widner, B Reibnegger, G Fuchs, D
Citation: F. Leblhuber et al., Hyperhomocysteinemia in dementia, J NEURAL TR, 107(12), 2000, pp. 1469-1474

Authors: Leblhuber, F Walli, J Demel, U Tilz, GP Widner, B Fuchs, D
Citation: F. Leblhuber et al., Increased serum neopterin concentrations in patients with Alzheimer's disease, CLIN CH L M, 37(4), 1999, pp. 429-431

Authors: Zachhuber, C Leblhuber, F Bancher, C Jellinger, K Drlicek, M
Citation: C. Zachhuber et al., Frontal lobe dementia - Clinicopathological case reports (vol 67, pg 68, 1998), F NEUR PSYC, 67(7), 1999, pp. 336-336

Authors: Zachhuber, C Leblhuber, F Bancher, C Jellinger, K Drlicek, M
Citation: C. Zachhuber et al., Frontal lobe dementia - Clinicopathological case reports, F NEUR PSYC, 67(2), 1999, pp. 68-74

Authors: Widner, B Leblhuber, F Fuchs, D
Citation: B. Widner et al., Abnormal potassium-channel function in platelets in Alzheimer's disease, LANCET, 353(9149), 1999, pp. 325-326

Authors: Blum-Degen, D Heinemann, T Lan, J Pedersen, V Leblhuber, F Paulus, W Riederer, P Gerlach, M
Citation: D. Blum-degen et al., Characterization and regional distribution of nitric oxide synthase in thehuman brain during normal ageing, BRAIN RES, 834(1-2), 1999, pp. 128-135

Authors: Kornhuber, J Schultz, A Wiltfang, J Meineke, I Gleiter, CH Zochling, R Boissl, KW Leblhuber, F Riederer, P
Citation: J. Kornhuber et al., Persistence of haloperidol in human brain tissue, AM J PSYCHI, 156(6), 1999, pp. 885-890

Authors: Kornhuber, J Jellinger, K Wiltfang, J Leblhuber, F Riederer, P
Citation: J. Kornhuber et al., The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue, ACT NEUROP, 98(1), 1999, pp. 85-90

Authors: Leblhuber, F Walli, J Jellinger, K Tilz, GP Widner, B Laccone, F Fuchs, D
Citation: F. Leblhuber et al., Activated immune system in patients with Huntington's disease, CLIN CH L M, 36(10), 1998, pp. 747-750
Risultati: 1-16 |